AIHTA - Publications - Search - Zanubrutinib (Brukinsa®) as monotherapy for the treatment of marginal zone lymphoma (MZL)

Rothschedl, E. and Wolf, S. (2022): Zanubrutinib (Brukinsa®) as monotherapy for the treatment of marginal zone lymphoma (MZL). Oncology Fact Sheet Nr. 110.

[thumbnail of Oncology Fact Sheet Nr.110.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
105kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WH Hemic and lymphatic systems
Language:English
Series Name:Oncology Fact Sheet Nr. 110
Deposited on:17 Oct 2022 12:17
Last Modified:17 Oct 2022 12:17

Repository Staff Only: item control page